Shenmai-Danshen (SM-DS) injection im-proved MDA, SOD, interleukin 6 (IL-6), and TNF-alpha levels and reduced the myocardial reperfusion injury in patients with acute myocardial infarction, after percutaneous coronary intervention (PCI) [193]. This evidence concerns the gene IL6 and myocardial infarction.